🇺🇸 FDA
Patent

US 8399458

Compounds useful as protein kinase inhibitors

granted A61KA61K31/55A61K31/551

Quick answer

US patent 8399458 (Compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/55, A61K31/551, A61K45/06, A61P